Company: OCEA
Filing Date: 2025-02-14
Form Type: PRE 14A
Source: 0001493152-25-006994
Chunk: 55

Company: Ocean Biomedical, Inc.
Filing Date: 2025-02-14
Form: PRE 14A
Chunk 55
---
 the proposal unless otherwise specified.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information regarding the beneficial ownership of the Company’s common stock as of January 28, 2025 by:

| ● | each                                                                                                                         
 person known by the Company to be the beneficial owner of more than 5% of the Company’s issued and outstanding common stock; |
| ● | each                                                                                                                         
 of the Company’s executive officers and directors; and                                                                       |
| ● | all                                                                                                                          
 of the Company’s executive officers and directors as a group.                                                                |

| 45 |

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if such person possesses, or has the right to acquire within 60 days, sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. The beneficial ownership of the Company’s common stock is based on _________ shares of Common Stock issued and outstanding as of January 27, 2025, unless otherwise indicated. There are currently no shares of Company preferred stock issued and outstanding. Currently, there are warrants to purchase approximately ___________ shares of the Company’s common stock issued and outstanding.

In computing the number of shares beneficially owned by a person or entity and the percentage ownership of that person or entity in the table below, all shares subject to options or warrants held by such person or entity were deemed outstanding if such options or warrants are currently exercisable or are exercisable within 60 days of February 20, 2025. These shares were not deemed outstanding, however, for the purpose of computing the percentage ownership of any other person or entity.

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares beneficially owned by them.

| Name of Beneficial Owner(1)                                                          |     | Number of Shares Beneficially Owned(2) |            |     | Percentage Of Outstanding Shares |
| Directors and Executive Officers of the Company:                                     |     |                                        |            |     |                                  |
| Dr. Chirinjeev Kathuria, M.D. (3) (4) (5)                                            |     |                                        | 22,199,608 |     |                                  |
| Elizabeth Ng (3)                                                                     |     |                                        |          — |     |                                  |
| Gurinder Kalra                                                                       |     |